Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0OYIZH |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | XiRB49 |
|||||
| Organization | Université Paris-Saclay.; INRAE.; Inria.; Université de Bourgogne.; Université Paris Cité.; Université Sorbonne Paris Nord. |
|||||
| Synonyms |
xiRB49
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antibody Subtype | Chimeric lgG |
|||||
| Antigen Name | Endothelin-1 (EDN1) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
XiRB49 MMAE [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.4۱.2 nM
|
Positive ET expression (ET+++/++) | ||
| Method Description |
Cell cytotoxicity was monitored using a specific assay (Abcam, Cambridge, UK- Cat # 112118). This cytotoxicity assay is based on the measurement of mitochondrial dehydrogenase activity using a specific dye. This assay evaluates the metabolic activity of viable cells. Cells were plated at 1500 cells/well in 100 ul culture medium. The following day, 100 ul of increasing concentrations of mAb, diluted in culture medium, were added to each well. Cells were incubated for 96 h at 37 °C in a 5% CO2 incubator. The OD570/OD605 nm ratio was used to determine cell viability in each well in triplicate according to the instructions. Data were analyzed using Prism 9.4 (GraphPad Software San Diego, CA, USA) to determine the half maximal inhibitory concentration (IC50) using the variable slope model after checking that we had a normal distribution of these data by a D'Agostino & Pearson test.
Click to Show/Hide
|
||||
| In Vitro Model | Melanoma | UACC-257 cells | CVCL_1779 | ||
References
